Dr. M's hire date is where I start the early history of Sigma science as potential MOA, and post reverse split is where I start the "modern-era" on NASDAQ.
A blast from the past July 8, 2013: "Additionally, Anavex is pleased to announce the appointment of seasoned healthcare executive Dr. Christopher U. Missling as Chief Executive Officer (“CEO”) of the Company."